Table 1 Patients characteristics
Characteristic | Number (%) |
|---|---|
Total number of patients | 46 |
Age (mean ± SD) | 50.8 ± 16.6 |
Range | 11–78 |
Gender | |
• Male | 27(58.7%) |
• Female | 19(41.3%) |
Tumor sites | |
• Larynx | 16 (34.8%) |
• Nasopharynx | 9 (19.6%) |
• Oropharynx | 1 (2.2%) |
• Hypopharynx | 10 (21.7%) |
• Oral tongue | 5 (10.9%) |
• Sinonasal | 3 (6.5%) |
• Palatal | 1 (2.2%) |
• Upper gingival | 1 (2.2%) |
Histologic grade of differentiation | |
• Well differentiated | 5 (10.9%) |
• Moderately differentiated | 29 (63%) |
• Undifferentiated | 12 (26.1%) |
TNM | |
T1 | 3 (6.5%) |
T2 | 3 (6.5%) |
T3 | 13 (28.3%) |
T4/T4a | 22 (47.8%) |
T4b | 5 (10.9%) |
N0 | 21 (45.7%) |
N1 | 5 (10.9%) |
N2 | 16 (34.8%) |
N3 | 4 (8.7%) |
Stage groups | |
II | 2 (4.3%) |
III | 11 (23.9%) |
IVA | 23 (50%) |
IVB | 10 (21.7%) |
Treatment | |
• Concomitant chemoradiation therapy | 39 (84.4%) |
• Radiation therapy | 7 (15.2%) |
• Neoadjuvant chemotherapy: | |
o Yes | 32 (69.6%) |
o No | 14 (30.4%) |